10.09.2013
- The Perfect Storm - More and more chemical and pharmaceutical companies are recognizing the need to make their processes more environmentally sustainable, a trend that is right at...
28.02.2013
- Codexis, a developer of engineered enzymes for pharmaceutical, biofuel and chemical production, today announced financial results for the fourth quarter and year ended December 31...
19.02.2013
- In October 2012, Almac announced a collaboration agreement with DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM in the field of...
18.02.2013
- Novozymes acquires Iogen Bio-Products, industrial enzyme business of Ottawa-based Iogen Corporation for CAD 67.5 million (approximately DKK 370 million) and potential earn-out...
29.01.2013
- Codexis, headquartered in Redwood City, California, USA is a developer of enzymes and processes for the production of pharmaceuticals, biofuels and bio-based chemicals. Following...
21.01.2013
- Danish industrial enzymes maker Novozymes said it aims to keep margins at the current high level over the next five years through production efficiency measures, helping send its...
08.10.2012
- Almac is delighted to announce a collaboration agreement with DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM, in the field of...
- Optimized by nature over the millennia, enzymes are catalysts that play a crucial role in the transformation and degradation of essential molecules in living organisms...
